Repligen | RGEN - Loan Capital

Stock Price
116.99
Daily Change
-1.30 -1.10%
Monthly
4.93%
Yearly
-16.09%
Q2 Forecast
115.08

Repligen reported $542.21M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agilent USD 3.05B 0 Dec/2025
Align Technology USD 0 0 Dec/2024
Bio Techne USD 260M 40M Dec/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Bruker USD 1.85B 131.7M Dec/2025
Charles River Laboratories USD 2.14B 49.09M Dec/2025
Danaher USD 17.56B 855M Mar/2026
Dentsply International USD 2.02B 2M Dec/2025
General Electric Aerospace USD 18.17B 634M Mar/2026
Henry Schein USD 2.31B 157M Dec/2025
Illumina USD 1.49B 496M Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Mettler Toledo International USD 2.09B 58.01M Dec/2025
Myriad Genetics USD 119.9M 400K Dec/2025
OraSure Technologies USD 100K 17K Dec/2025
Pacific Biosciences Of California USD 645.38M 223K Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Repligen USD 542.21M 4.29M Dec/2025
Revvity USD 2.63B 543K Dec/2025
Standard Biotools USD 299K 0 Dec/2025
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Waters USD 1.41B 460.24M Dec/2025
West Pharmaceutical Services USD 202.8M 0 Mar/2026